Exploring SARS-CoV-2 and Plasmodium falciparum coinfection in human erythrocytes

The co-occurrence and the similarities between malaria and COVID-19 diseases raise the question of whether SARS-CoV-2 is capable of infecting red blood cells and, if so, whether these cells represent a competent niche for the virus. In this study, we first tested whether CD147 functions as an altern...

Full description

Bibliographic Details
Main Authors: Diana López-Farfán, Nerea Irigoyen, Elena Gómez-Díaz
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1120298/full
_version_ 1827991394742960128
author Diana López-Farfán
Nerea Irigoyen
Elena Gómez-Díaz
author_facet Diana López-Farfán
Nerea Irigoyen
Elena Gómez-Díaz
author_sort Diana López-Farfán
collection DOAJ
description The co-occurrence and the similarities between malaria and COVID-19 diseases raise the question of whether SARS-CoV-2 is capable of infecting red blood cells and, if so, whether these cells represent a competent niche for the virus. In this study, we first tested whether CD147 functions as an alternative receptor of SARS-CoV-2 to infect host cells. Our results show that transient expression of ACE2 but not CD147 in HEK293T allows SARS-CoV-2 pseudoviruses entry and infection. Secondly, using a SARS-CoV-2 wild type virus isolate we tested whether the new coronavirus could bind and enter erythrocytes. Here, we report that 10,94% of red blood cells had SARS-CoV-2 bound to the membrane or inside the cell. Finally, we hypothesized that the presence of the malaria parasite, Plasmodium falciparum, could make erythrocytes more vulnerable to SARS-CoV-2 infection due to red blood cell membrane remodelling. However, we found a low coinfection rate (9,13%), suggesting that P. falciparum would not facilitate the entry of SARS-CoV-2 virus into malaria-infected erythrocytes. Besides, the presence of SARS-CoV-2 in a P. falciparum blood culture did not affect the survival or growth rate of the malaria parasite. Our results are significant because they do not support the role of CD147 in SARS-CoV-2 infection, and indicate, that mature erythrocytes would not be an important reservoir for the virus in our body, although they can be transiently infected.
first_indexed 2024-04-10T00:51:09Z
format Article
id doaj.art-c0b93700b5764592b49caa36b27123b0
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-10T00:51:09Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-c0b93700b5764592b49caa36b27123b02023-03-13T10:44:25ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-03-011410.3389/fimmu.2023.11202981120298Exploring SARS-CoV-2 and Plasmodium falciparum coinfection in human erythrocytesDiana López-Farfán0Nerea Irigoyen1Elena Gómez-Díaz2Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas (IPBLN, CSIC), Granada, SpainDivision of Virology, Department of Pathology, University of Cambridge, Cambridge, United KingdomInstituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas (IPBLN, CSIC), Granada, SpainThe co-occurrence and the similarities between malaria and COVID-19 diseases raise the question of whether SARS-CoV-2 is capable of infecting red blood cells and, if so, whether these cells represent a competent niche for the virus. In this study, we first tested whether CD147 functions as an alternative receptor of SARS-CoV-2 to infect host cells. Our results show that transient expression of ACE2 but not CD147 in HEK293T allows SARS-CoV-2 pseudoviruses entry and infection. Secondly, using a SARS-CoV-2 wild type virus isolate we tested whether the new coronavirus could bind and enter erythrocytes. Here, we report that 10,94% of red blood cells had SARS-CoV-2 bound to the membrane or inside the cell. Finally, we hypothesized that the presence of the malaria parasite, Plasmodium falciparum, could make erythrocytes more vulnerable to SARS-CoV-2 infection due to red blood cell membrane remodelling. However, we found a low coinfection rate (9,13%), suggesting that P. falciparum would not facilitate the entry of SARS-CoV-2 virus into malaria-infected erythrocytes. Besides, the presence of SARS-CoV-2 in a P. falciparum blood culture did not affect the survival or growth rate of the malaria parasite. Our results are significant because they do not support the role of CD147 in SARS-CoV-2 infection, and indicate, that mature erythrocytes would not be an important reservoir for the virus in our body, although they can be transiently infected.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1120298/fullCOVID-19malarianovel coronavirusACE2CD147red blood cells
spellingShingle Diana López-Farfán
Nerea Irigoyen
Elena Gómez-Díaz
Exploring SARS-CoV-2 and Plasmodium falciparum coinfection in human erythrocytes
Frontiers in Immunology
COVID-19
malaria
novel coronavirus
ACE2
CD147
red blood cells
title Exploring SARS-CoV-2 and Plasmodium falciparum coinfection in human erythrocytes
title_full Exploring SARS-CoV-2 and Plasmodium falciparum coinfection in human erythrocytes
title_fullStr Exploring SARS-CoV-2 and Plasmodium falciparum coinfection in human erythrocytes
title_full_unstemmed Exploring SARS-CoV-2 and Plasmodium falciparum coinfection in human erythrocytes
title_short Exploring SARS-CoV-2 and Plasmodium falciparum coinfection in human erythrocytes
title_sort exploring sars cov 2 and plasmodium falciparum coinfection in human erythrocytes
topic COVID-19
malaria
novel coronavirus
ACE2
CD147
red blood cells
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1120298/full
work_keys_str_mv AT dianalopezfarfan exploringsarscov2andplasmodiumfalciparumcoinfectioninhumanerythrocytes
AT nereairigoyen exploringsarscov2andplasmodiumfalciparumcoinfectioninhumanerythrocytes
AT elenagomezdiaz exploringsarscov2andplasmodiumfalciparumcoinfectioninhumanerythrocytes